First patient dosed in Qlaris Bio's phase 2 Nightingale clinical trial for QLS-111

Published on August 26, 2025
The study will be evaluating the safety, tolerability, and efficacy of QLS-111 in adult patients with normal tension glaucoma.
Continue reading on website
Other news

The important role daily disposables play in your practice

August 26, 2025
Sheila Setork, OD, gives insight and advice on how to optimize daily disposables in order to improve retention rates and introduce more patients to contact lenses.

The National Average for Gross Revenue at ECP Locations Increased for the Week of August 18–24, Jobson’s Latest Practice Performance Tracker Shows

August 27, 2025
NEWARK, N.J.—The national average for gross revenue at ECP locations increased last week, August 18–24, when compared with the previous week, at a rate of 1 index point. That places gross revenue at a level 10 index points above where it was at this point in time (Week 34) when compared with last year (2024), 30 points above the same period in 2023, 30 points above 2022, 40 points above 2021, 34 p